+ All Categories

Home > Documents > Clinical Application of HER2-Directed Therapies in Breast Cancer

Clinical Application of HER2-Directed Therapies in Breast Cancer

Date post:	31-Dec-2015
Category:	Documents
Upload:	benjamin-gonzales
View:	29 times
Download:	0 times

Download Report this document

Share this document with a friend

Description:

Clinical Application of HER2-Directed Therapies in Breast Cancer. HERA Results: Adjuvant Trastuzumab (8-Year Follow-up): OS – 2 y vs 1 y. ALTTO Trial: Schema. MARIANNE: Phase 3 Trial in HER2+ Breast Cancer (Locally Recurrent/Progressive Advanced or Metastatic). Abbreviations. - PowerPoint PPT Presentation

Embed Size (px):

Popular Tags:

her2 breast cancer

breast cancerhera results

adjuvant trastuzumab

18

Transcript

Page 1: Clinical Application of HER2-Directed Therapies in Breast Cancer

Page 2: Clinical Application of HER2-Directed Therapies in Breast Cancer

Page 3: Clinical Application of HER2-Directed Therapies in Breast Cancer

Page 4: Clinical Application of HER2-Directed Therapies in Breast Cancer

Page 5: Clinical Application of HER2-Directed Therapies in Breast Cancer

Page 6: Clinical Application of HER2-Directed Therapies in Breast Cancer

Page 7: Clinical Application of HER2-Directed Therapies in Breast Cancer

Page 8: Clinical Application of HER2-Directed Therapies in Breast Cancer

Page 9: Clinical Application of HER2-Directed Therapies in Breast Cancer

Page 10: Clinical Application of HER2-Directed Therapies in Breast Cancer

Page 11: Clinical Application of HER2-Directed Therapies in Breast Cancer

Page 12: Clinical Application of HER2-Directed Therapies in Breast Cancer

Page 13: Clinical Application of HER2-Directed Therapies in Breast Cancer

Page 14: Clinical Application of HER2-Directed Therapies in Breast Cancer

Page 15: Clinical Application of HER2-Directed Therapies in Breast Cancer

Page 16: Clinical Application of HER2-Directed Therapies in Breast Cancer

Page 17: Clinical Application of HER2-Directed Therapies in Breast Cancer

Page 18: Clinical Application of HER2-Directed Therapies in Breast Cancer

Recommended

Overcoming resistance to endocrine or HER2-directed therapy · Winship Cancer Institute | Emory University 2 Background • While most patients with ER+ breast cancer will do well

Treatment of Advanced Breast Cancer (ABC): The Expanding Landscape of Targeted Therapies · 2019-03-15 · • Target therapies • Luminal breast cancer • Her2-positive breast

Optimizing Anti-HER2 Therapies for HER2 Positive Breast ...gbcc.kr/upload/GBCC Anti-HER2 Therapy Takano 20190426.pdfResults will be reported at SABCS 2019 Nivolumab Evaluation With

Novel Therapies for Triple Negative, HER2+ and ER+ Breast ......HER2+ Breast Cancer Following Adjuvant Trastuzumab: Risk of Locoregional or Distant Recurrence Approximately 20% of

Inhibition of abnormal HER2-driven signaling by two HER2 ...€¦ · • These results suggest a new sub-group of breast cancer patients, HER2- with abnormal HER2 signaling (HER2-/HER2

Treatment of Advanced HR+/HER2- Breast Cancer · 2018-11-29 · therapies in the treatment of HR+/HER2- advanced breast cancer patients • Integrate clinical data regarding the use

SBT6050, a HER2-Directed TLR8 Therapeutic, is a Systemically Administered, Tumor ... · 2020. 5. 28. · HER2-expressing or HER2 negative EMT6 tumor cells 60 days after initial tumor

Treating HER2-mutant advanced biliary tract cancer … 3, 2019 – ESMO GI...Treating HER2-mutant advanced biliary tract cancer with neratinib: benefits of HER2 -directed targeted

Open Access Protocol Use and outcomes of targeted therapies in … · Use and outcomes of targeted therapies in early and metastatic HER2-positive breast cancer in Australia: protocol

Targeted Therapies in Gastric Cancer : Where Do We Stand …...Trastuzumab in combination with chemotherapy can now be considered a new standard of care for patients with HER2-positive

Chapter 13 Overview Insight therapies Insight therapies Relationship therapies Relationship therapies Behavior therapies Behavior therapies Cognitive therapies.

InTech-Alternative Therapies for Septic Shock Beyond Early Goal Directed Therapy

Pioneering New Therapies for Cancer Lymphocytic Leukemia Relapsed/refractory del(17p) Venclexta (venetoclax) ME-344 Mitochondrial Inhibitor HER2- Breast Cancer** Treatment-naïve,

Sponsored By:. SABCS 2011 Review: HER2-Directed Therapy in Breast Cancer Chau Dang, MD Assistant Professor of Medicine Weill Cornell Medical College Breast.

MICROBIOME-DIRECTED THERAPIES: PAST, PRESENT, AND …

New Drug Development in HER2+ Breast Cancer › pdf › 3. AFTIMOS.pdf · The Trastuzumab (Herceptin®) Story 1979: HER2 oncogene discovery 1984: HER2 protein discovery 1987: HER2

HER2/neu-directed therapy for biliary tract cancer · 2017-08-29 · RESEARCH ARTICLE Open Access HER2/neu-directed therapy for biliary tract cancer Milind Javle1*, Chaitanya Churi1,